NO973948D0 - 4-Aminotetrahydrobenzisoksazol eller -isotiazolforbindelser - Google Patents

4-Aminotetrahydrobenzisoksazol eller -isotiazolforbindelser

Info

Publication number: NO973948D0
Authority: NO; Norway
Prior art keywords: aminotetrahydrobenzisoxazole; disorders; isothiazole compounds; disease; aminotetrahydrobenzisoxazoles
Prior art date: 1995-02-28

Application number

NO973948A

Other languages

English (en)

Other versions

NO973948L (no

NO309474B1 (no

Inventor

Erik Falch

Povl Krogsgaard-Larsen

Jens Kristian Perregaard

Bente Froelund

Arne Schousboe

Lenz Sibylle Moltzen

Original Assignee

Lundbeck & Co As H

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-02-28

Filing date

1997-08-27

Publication date

1997-08-27

1997-08-27 Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H

1997-08-27 Publication of NO973948L publication Critical patent/NO973948L/no

1997-08-27 Publication of NO973948D0 publication Critical patent/NO973948D0/no

2001-02-05 Publication of NO309474B1 publication Critical patent/NO309474B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Thiazole And Isothizaole Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nozzles (AREA)

NO973948A 1995-02-28 1997-08-27 4-Aminotetrahydrobenzisoksazol eller -isotiazolforbindelser NO309474B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DK20795		1995-02-28
PCT/DK1996/000084 WO1996026929A1 (en)	1995-02-28	1996-02-28	4-aminotetrahydrobenzisoxazole or -isothiazole compounds

Publications (3)

Publication Number	Publication Date
NO973948L NO973948L (no)	1997-08-27
NO973948D0 true NO973948D0 (no)	1997-08-27
NO309474B1 NO309474B1 (no)	2001-02-05

Family

ID=8090951

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO973948A NO309474B1 (no)	1995-02-28	1997-08-27	4-Aminotetrahydrobenzisoksazol eller -isotiazolforbindelser

Country Status (30)

Country	Link
US (2)	US5998613A (no)
EP (1)	EP0812318B1 (no)
JP (1)	JPH11501016A (no)
KR (1)	KR100242675B1 (no)
CN (1)	CN1087290C (no)
AT (1)	ATE317391T1 (no)
AU (1)	AU697610B2 (no)
BG (1)	BG63258B1 (no)
BR (1)	BR9607443A (no)
CA (1)	CA2213127A1 (no)
CZ (1)	CZ290837B6 (no)
DE (1)	DE69635798T2 (no)
DK (1)	DK0812318T3 (no)
EA (1)	EA000380B1 (no)
EE (1)	EE03483B1 (no)
ES (1)	ES2253748T3 (no)
FI (1)	FI973519A0 (no)
HU (1)	HUP9800631A3 (no)
IL (1)	IL117295A (no)
IS (1)	IS2352B (no)
NO (1)	NO309474B1 (no)
NZ (1)	NZ301653A (no)
PL (1)	PL187404B1 (no)
RO (1)	RO119545B1 (no)
SI (1)	SI0812318T1 (no)
SK (1)	SK281879B6 (no)
TR (1)	TR199700873T1 (no)
UA (1)	UA43396C2 (no)
WO (1)	WO1996026929A1 (no)
ZA (1)	ZA961591B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1094757C (zh)	1996-07-24	2002-11-27	沃尼尔·朗伯公司	用于治疗疼痛的异丁基γ－氨基丁酸及其衍生物
GB9622370D0 (en) *	1996-10-28	1997-01-08	Merck Sharp & Dohme	Therapeutic agents
US20030185754A1 (en) *	2001-01-16	2003-10-02	Genset, S.A.	Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists
US20030166554A1 (en) *	2001-01-16	2003-09-04	Genset, S.A.	Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists
US7417040B2 (en) *	2004-03-01	2008-08-26	Bristol-Myers Squibb Company	Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
US7378426B2 (en) *	2004-03-01	2008-05-27	Bristol-Myers Squibb Company	Fused heterotricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
CN102414208B (zh) *	2009-05-05	2014-11-05	霍夫曼-拉罗奇有限公司	作为用于认知性障碍的治疗中的gaba a受体逆激动剂的异*唑-噻唑衍生物
WO2010151711A1 (en)	2009-06-25	2010-12-29	Alkermes, Inc.	Prodrugs of nh-acidic compounds
CN105758807B (zh) *	2016-02-22	2019-01-29	山东出入境检验检疫局检验检疫技术中心	一种鉴别废润滑油的方法
AU2019230014B2 (en)	2018-03-05	2024-11-28	Alkermes Pharma Ireland Limited	Aripiprazole dosing strategy

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2602643C2 (de) *	1976-01-24	1984-12-20	Bayer Ag, 5090 Leverkusen	1,2-Benzisothiazolinone-3, Verfahren zu ihrer Herstellung sowie Arzneimittel
US4411901A (en) *	1981-12-23	1983-10-25	Mead Johnson & Company	Benzisothiazole and benzisoxazole piperazine derivatives
US4452799A (en) *	1981-12-23	1984-06-05	Mead Johnson & Company	Benzisothiazole and benzisoxazole piperazine derivatives
US4514414A (en) *	1982-10-25	1985-04-30	Smithkline Beckman Corporation	N-Substituted pyrrolidineacetic acids and their esters
US4804663A (en)	1985-03-27	1989-02-14	Janssen Pharmaceutica N.V.	3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
DK288385D0 (da) *	1985-06-26	1985-06-26	Novo Industri As	Aminosyrederivater
US5321037A (en) *	1986-12-26	1994-06-14	Sankyo Company, Limited	Isoxazole derivatives for use as cerebro-active drugs and central muscle relaxants
ZA879631B (en) *	1986-12-26	1989-08-30	Sankyo Co	Centrally-acting muscle relaxants
US5225412A (en) *	1991-04-29	1993-07-06	Hoechst-Roussel Pharmaceuticals Incorporated	Benzoisothiazole-and benzisoxazole-3-carboxamides
US5143923B1 (en) *	1991-04-29	1993-11-02	Hoechst-Roussel Pharmaceuticals Incorporated	Benzoisothiazole-and benzisoxazole-3-carboxamides

1996
- 1996-02-28 IL IL11729596A patent/IL117295A/xx not_active IP Right Cessation
- 1996-02-28 CN CN96192160A patent/CN1087290C/zh not_active Expired - Fee Related
- 1996-02-28 EE EE9700197A patent/EE03483B1/xx not_active IP Right Cessation
- 1996-02-28 KR KR1019970705952A patent/KR100242675B1/ko not_active Expired - Fee Related
- 1996-02-28 TR TR97/00873T patent/TR199700873T1/xx unknown
- 1996-02-28 CZ CZ19972711A patent/CZ290837B6/cs not_active IP Right Cessation
- 1996-02-28 BR BR9607443A patent/BR9607443A/pt not_active IP Right Cessation
- 1996-02-28 AU AU47131/96A patent/AU697610B2/en not_active Ceased
- 1996-02-28 EA EA199700199A patent/EA000380B1/ru not_active IP Right Cessation
- 1996-02-28 AT AT96902908T patent/ATE317391T1/de not_active IP Right Cessation
- 1996-02-28 HU HU9800631A patent/HUP9800631A3/hu unknown
- 1996-02-28 NZ NZ301653A patent/NZ301653A/xx unknown
- 1996-02-28 DE DE69635798T patent/DE69635798T2/de not_active Expired - Fee Related
- 1996-02-28 SI SI9630731T patent/SI0812318T1/sl unknown
- 1996-02-28 PL PL96321956A patent/PL187404B1/pl not_active IP Right Cessation
- 1996-02-28 JP JP8525968A patent/JPH11501016A/ja active Pending
- 1996-02-28 RO RO97-01639A patent/RO119545B1/ro unknown
- 1996-02-28 ES ES96902908T patent/ES2253748T3/es not_active Expired - Lifetime
- 1996-02-28 FI FI973519A patent/FI973519A0/fi not_active Application Discontinuation
- 1996-02-28 WO PCT/DK1996/000084 patent/WO1996026929A1/en not_active Ceased
- 1996-02-28 SK SK1151-97A patent/SK281879B6/sk not_active IP Right Cessation
- 1996-02-28 UA UA97094741A patent/UA43396C2/uk unknown
- 1996-02-28 EP EP96902908A patent/EP0812318B1/en not_active Expired - Lifetime
- 1996-02-28 CA CA002213127A patent/CA2213127A1/en not_active Abandoned
- 1996-02-28 ZA ZA961591A patent/ZA961591B/xx unknown
- 1996-02-28 DK DK96902908T patent/DK0812318T3/da active
1997
- 1997-08-05 US US08/942,467 patent/US5998613A/en not_active Expired - Fee Related
- 1997-08-13 IS IS4542A patent/IS2352B/is unknown
- 1997-08-27 NO NO973948A patent/NO309474B1/no unknown
- 1997-09-16 BG BG101894A patent/BG63258B1/bg unknown
1999
- 1999-10-05 US US09/412,721 patent/US6174909B1/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
IL117295A0 (en)	1996-06-18
KR100242675B1 (ko)	2000-03-02
EA000380B1 (ru)	1999-06-24
CZ290837B6 (cs)	2002-10-16
EP0812318B1 (en)	2006-02-08
EP0812318A1 (en)	1997-12-17
BR9607443A (pt)	1998-05-26
IL117295A (en)	1999-11-30
TR199700873T1 (xx)	1998-01-21
CZ271197A3 (cs)	1998-03-18
HUP9800631A3 (en)	1998-12-28
US5998613A (en)	1999-12-07
ZA961591B (en)	1996-08-28
PL321956A1 (en)	1998-01-05
CN1176638A (zh)	1998-03-18
RO119545B1 (ro)	2004-12-30
SK115197A3 (en)	1998-02-04
AU697610B2 (en)	1998-10-15
NO973948L (no)	1997-08-27
WO1996026929A1 (en)	1996-09-06
HK1008527A1 (en)	1999-07-30
PL187404B1 (pl)	2004-07-30
DE69635798T2 (de)	2006-08-17
HUP9800631A2 (hu)	1998-08-28
EE03483B1 (et)	2001-08-15
JPH11501016A (ja)	1999-01-26
IS2352B (is)	2008-04-15
NO309474B1 (no)	2001-02-05
SK281879B6 (sk)	2001-08-06
ATE317391T1 (de)	2006-02-15
BG63258B1 (bg)	2001-07-31
FI973519L (fi)	1997-08-27
EE9700197A (et)	1998-02-16
NZ301653A (en)	1998-12-23
DK0812318T3 (da)	2006-06-06
FI973519A7 (fi)	1997-08-27
SI0812318T1 (sl)	2006-06-30
CN1087290C (zh)	2002-07-10
FI973519A0 (fi)	1997-08-27
AU4713196A (en)	1996-09-18
BG101894A (bg)	1998-05-29
IS4542A (is)	1997-08-13
EA199700199A1 (ru)	1998-02-26
UA43396C2 (uk)	2001-12-17
US6174909B1 (en)	2001-01-16
ES2253748T3 (es)	2006-06-01
KR19980702546A (ko)	1998-07-15
DE69635798D1 (de)	2006-04-20
MX9706280A (es)	1998-06-30
CA2213127A1 (en)	1996-09-06

Publication	Publication Date	Title
DE60224879D1 (de)	2008-03-20	Verwendung von dpiv-inhibitoren als therapeutika für krankhafte neurologische zustände
ATE168007T1 (de)	1998-07-15	Zur behandlung von erkrankungen des zentralnervensystems verwendbare benzimidazole
WO1993000330A3 (en)	1993-03-04	Azanorbornane derivatives
BR0314721A (pt)	2005-08-02	Compostos tricìclicos úteis para tratamento de distúrbios inflamatórios e alérgicos, processo para sua preparação e composições farmacêuticas contendo-os
AU5584901A (en)	2001-10-30	Use of cyclic gmp-specific phosphodiesterase inhibitors for treatment of parkinson's disease
GR3029853T3 (en)	1999-07-30	Diazabicyclic neurokinin antagonists
SG157231A1 (en)	2009-12-29	Substituted p-diaminobenzene derivatives
DE69615682D1 (de)	2001-11-08	N-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1-h-benzo[b][1,5]-diazepin-3-yl)-acetamide
ATE241354T1 (de)	2003-06-15	Verwendung von 5-(tetradecyloxy)-2-furan carbonsäure für die behandlung von alzheimer krankheit oder psychosis
NO973948L (no)	1997-08-27	4-Aminotetrahydrobenzisoksazol eller -isotiazolforbindelser
NO903726D0 (no)	1990-08-24	Rensing av 1,1-diklor-1-fluoretan.
FR2608607B1 (fr)	1989-04-28	Procede de preparation de thienylethylamines et dithienylethylamines ainsi obtenues
AP2003002873A0 (en)	2003-09-30	Pregabalin lactose conjugates
ATE309200T1 (de)	2005-11-15	Antikonvulsive und zns-aktive bis-fluoralkylamide
ATE152708T1 (de)	1997-05-15	(1,2n) und (3,2n)-karbozyklische-2-amino- tetralinderivate
MY121206A (en)	2006-01-28	Aminobenzamide compounds for the treatment of neurodegenerative disorders
DK0804186T3 (da)	2002-06-17	Indolditerpenalkaloidforbindelser
EP1640359A3 (en)	2006-04-05	Anticonvulsant and central nervous system-active bis(fluorophenyl)alkylamides
ES2117934B1 (es)	1999-04-01	Tetrahidropiridinas (0 4-hidroxipiperidinas) alquilazoles.